Clin Lung Cancer
-
Publication Venue For
- Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer.. 23:e317-e320. 2022
- Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial.. 23:e247-e251. 2022
- Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.. 23:177-184. 2022
- Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.. 22:500-509. 2021
- Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the Lung.. 22:e646-e653. 2021
- Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.. 21:e523-e527. 2020
- Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901.. 21:553-561.e1. 2020
- Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival.. 21:407-414. 2020
- Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.. 21:238-246. 2020
- Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.. 20:e601-e608. 2019
- Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non-Small-Cell Lung Cancer.. 19:e481-e487. 2018
- Sequential CT Findings in Patients With Non-small-cell Lung Cancer Receiving Nivolumab.. 19:175-180. 2018
- Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs.. 18:401-409. 2017
- Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall.. 18:e259-e265. 2017
- Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.. 18:e57-e70. 2017
- Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.. 17:419-426. 2016
- Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.. 17:253-262.e5. 2016
- Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.. 17:47-55. 2016
- Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.. 16:e37-e53. 2015
- Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.. 14:452-456. 2013
- Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors.. 14:425-432. 2013
- Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium.. 14:446-451. 2013
- Analysis of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective radiologic endpoin.. 14:267-274. 2013
- International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control.. 13:225-235. 2012
- Small-cell lung cancer: prognostic factors and changing treatment over 15 years.. 13:115-122. 2012
- Consensus statement on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control.. 13:1-5. 2012
- Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.. 10:244-248. 2009
- Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia. 2018